TheraVet S.A. is a Walloon biotech company, created in November 2017 which develops innovative treatments for high unmet medical need osteoarticular conditions (e.g., joint, tendon/ligament and bone) for small companion animals such as dogs. TheraVet's mature product portfolio is composed of biological as well as synthetic products developed from clinical stage and marketed human products.